Cyclophosphamide Versus Obinutuzumab for the Treatment of Anti-MDA5 Positive Inflammatory Myopathy with Interstitial Lung Disease: A Study Protocol and Literature Review
In patients with idiopathic inflammatory myopathy, the presence of the melanoma differentiation-associated gene 5 (MDA5) antibody carries an extremely poor prognosis as a result of the associated interstitial lung disease (ILD) that is often rapidly progressive and refractory to therapies. Managemen...
Main Authors: | Ho So, Chi Chiu Mok |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2019-12-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Subjects: | |
Online Access: | http://www.worldscientific.com/doi/epdf/10.1142/S2661341719300040 |
Similar Items
-
Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
by: Baptiste Hervier, et al.
Published: (2020-01-01) -
The lungs were on fire: a pilot study of 18F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
by: Junyu Liang, et al.
Published: (2021-07-01) -
MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
by: Safi Alqatari, et al.
Published: (2018-04-01) -
Idiopathic inflammatory myopathies: Contributions from India
by: Anand Narayan Malaviya
Published: (2020-01-01) -
Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
by: Junyu Liang, et al.
Published: (2021-02-01)